Infection indication | Iron | Control | Iron per 50 visits n = 26,473 | Control per 50 visits n = 27,633 | Incidence ratioa
(95% CI) |
P value | PFDRb
|
---|
Malariac
| 41 | 28 | 0.077 | 0.051 | 1.53 (0.94–2.47) | 0.084 | 0.278 |
Respiratory | 75 | 87 | 0.142 | 0.157 | 0.90 (0.66–1.23) | 0.503 | 0.719 |
Locald
| 75 | 57 | 0.142 | 0.103 | 1.37 (0.97–1.94) | 0.071 | 0.278 |
Gastrointestinale
| 62 | 30 | 0.117 | 0.054 | 2.16 (1.39–3.34) | <0.001 | 0.005 |
Urinary tractf
| 10 | 9 | 0.019 | 0.016 | 1.16 (0.47–2.86) | 0.747 | 0.934 |
STIg
| 13 | 7 | 0.025 | 0.013 | 1.94 (0.77–4.86) | 0.158 | 0.292 |
Genitalh
| 15 | 16 | 0.028 | 0.029 | 0.98 (0.48–1.98) | 0.952 | 0.993 |
Dental | 11 | 5 | 0.021 | 0.009 | 2.30 (0.80–6.62) | 0.123 | 0.292 |
Meningitis | 0 | 3 | 0 | 0.005 | 0 (NA) | 0.993 | 0.993 |
Miscellaneousi
| 29 | 42 | 0.055 | 0.076 | 0.72 (0.45–1.16) | 0.175 | 0.292 |
-
aIncidence ratio was computed using Poisson regression with the number of visits as the exposure period
-
b
P value adjusted for multiple testing using false discovery rate method [26]
-
cAntibiotics in addition to anti-malarial treatment
-
dNon-enteric and non-respiratory, includes ear, skin, ophthalmic, abscess, wounds, local trauma, sinusitis, mastoiditis, keloid, scalp ringworm
-
eDysentry, typhoid, enteritis, intestinal parasitosis, gastric ulcer, gastroenteritis, diarrhoea and abdominal pain, vomiting and abdominal pain, amoebiasis, colopathy, sub-occlusion
-
fCystitis, dysuria
-
gIncludes syphilis, trichomoniasis
-
hUpper or lower genital infection
-
iItching, colic, headache, generalised or localised pain, fever, vomiting only, anaemia, anxiety, neuralgia, spasms, urticarial, plus non-infectious specific diagnoses: cancers, fertility problems, angina, self-medication, allergy, burns, renal stones, contraception, thyroid and cardiac diseases, epilepsy, filariasis, foreign body, venomous bites, fractures, migraine, HIV, varicella, mumps, prophylactic and non-classifiable: includes three uncertain descriptors, or absent statement
-
PFDR positive false discovery rate, STI sexually transmitted infection